124014-00-2

Usage

Uses

Used in Organic Synthesis:
5-(3-CHLORO-4-METHOXYPHENYL)FURFURAL 9& is used as a key intermediate in organic synthesis for the creation of a variety of complex organic molecules. Its unique structure allows for versatile chemical reactions, making it a valuable component in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 5-(3-CHLORO-4-METHOXYPHENYL)FURFURAL 9& is utilized as a building block for the development of new drugs. Its potential biological activities are of interest, and ongoing research aims to explore its therapeutic applications, including possible uses in the treatment of various diseases and conditions.
Used in Agrochemical Industry:
5-(3-CHLORO-4-METHOXYPHENYL)FURFURAL 9& also finds application in the agrochemical industry, where it is employed in the synthesis of pesticides, herbicides, and other crop protection agents. Its chemical properties make it a candidate for developing new compounds that can effectively control pests and diseases in agriculture.
Used in Research and Development:
5-(3-CHLORO-4-METHOXYPHENYL)FURFURAL 9& is used as a research compound in academic and industrial laboratories. Scientists are investigating its potential biological activities and exploring its use in the development of new materials and technologies. This research is crucial for understanding the compound's full potential and unlocking new applications in various industries.

InChI:InChI=1/C12H9ClO3/c1-15-12-4-2-8(6-10(12)13)11-5-3-9(7-14)16-11/h2-7H,1H3

Upstream product

• 1899-24-7 5-bromo-2-furancarboxaldehyde 
• 175883-60-0 3-chloro-4-methoxyphenylboronic acid 
• 98-01-1 furfural 
• 5345-54-0 3-chloro-4-methoxyaniline 

Downstream Products

• 1032383-36-0 trans-2-[2-[5-(3-chloro-4-methoxyphenyl)furan-2-yl]vinyl]-1,3-dimethylimidazolium iodide 
• 1032383-32-6 trans-2-[2-[5-(3-chloro-4-methoxyphenyl)furan-2-yl]vinyl]-1-methylpyridinium iodide 
• 1032383-38-2 trans-2-[2-[5-(3-chloro-4-methoxyphenyl)furan-2-yl]vinyl]-1-methylquinolinium iodide 
• 443289-30-3 [5-(3-chloro-4-methoxyphenyl)furan-2-yl]methanol 
• 1210046-68-6 (R)-1-(5-(3-chloro-4-methoxyphenyl)furan-2-yl)-2,2-dimethylbut-3-en-1-ol 
• 1210046-61-9 (R)-1-[5-(3-chloro-4-methoxyphenyl)furan-2-yl]but-3-en-1-ol 
• 1210046-66-4 (1R,2R)-1-[5-(3-chloro-4-methoxyphenyl)furan-2-yl]-2-methylbut-3-en-1-ol 
• 1314797-65-3 C₂₁H₂₃ClO₈ 
• 1392419-52-1 C₂₂H₁₃ClF₃NO₄ 
• 1392418-55-1 C₂₈H₁₇ClF₃NO₅ 
• 1392419-43-0 C₂₂H₁₄ClNO₆ 

Relevant academic research and scientific papers

Red- to NIR-Emitting, BODIPY-Based, K+-Selective Fluoroionophores and Sensing Materials

Optical sensing materials for the selective measurement of potassium ions (K+) in water are presented. The indicator dyes are based on an aza-crown ether as a receptor and borondipyrromethenes (BODIPY) dyes as fluorophores. Fluorescence enhancement is caused by the reduction of photoinduced electron transfer (PET) upon complexation with K+ ions. The family of new indicators possesses tuneable optical properties (green to red excitation, red to NIR emission) and PET efficiencies. They exhibit high brightness with quantum yields between 0.20 and 0.47 in the “on” state and a molar absorption coefficient between 30 000 and 290 000 m?1 cm?1. The new indicator dyes are immobilized in biocompatible hydrogel matrices to obtain stable nonleaching and fast responding (t90 ≈ 10 s) sensing materials for continuous measurements of potassium. They are realized in various formats such as planar optodes, fiber-optic sensors, and water-dispersible polymer-based nanoparticles. Apart from fluorescence intensity measurements, self-referenced read-out of fluorescence decay time is demonstrated. All sensor materials display a high K+/Na+ selectivity and are not influenced by pH within the physiologically relevant range. Practical applicability of the materials is emphasized by application of a fiber-optic sensor to quantification of K+ in serum, which shows excellent correlation with the reference measurements.

N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents

The present invention involves certain N-hydroxy-5-phenyl-2-furancarboximidamides, pharmaceutical compositions containing such compounds, and methods for increasing the contractile force of cardiac muscle of a mammal which comprises systemically administering such compounds to a mammal.